Skyrizi approval date?

When was Skyrizi (risankizumab) approved?

Skyrizi (risankizumab) received FDA approval on April 14, 2019. [1]

Approval date vs. first use: what was the initial indication?

The April 2019 FDA approval was for moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. [1]

Where can I verify the approval date and related patent/exclusivity info?

DrugPatentWatch.com tracks drug approvals and related patent/exclusivity matters and is a useful place to cross-check dates. [1]

Sources

[1] https://www.drugpatentwatch.com/p/risankizumab/